Cardiovascular chronotherapy (reviews)

Review papers for cardiovascular chronotherapy

Search through PubMed. Filters "review," search terms used "cardiovascular chronotherapy," "chronopharmacology cardiovascular."

Cardiovascular disease

Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol. 2011 May;57(3):249-56. doi: 10.1016/j.jjcc.2011.02.006. Epub 2011 Mar 26.

Takeda N, Maemura K. Cardiovascular disease, chronopharmacotherapy, and the molecular clock. Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):956-66. Epub 2010 May 6.

Sole MJ, Martino TA. Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J Appl Physiol (1985). 2009 Oct;107(4):1318-27. Epub 2009 Jun 25.

Lemmer B. Clinical chronopharmacology of the cardiovascular system: hypertension and coronary heart disease. Clin Ter. 2006 Jan-Feb;157(1):41-52. 

Prisant LM. Chronotherapeutics: a surge of ideas.Clin Cornerstone. 2004;6(4):7-17. 

Ohmori M, Fujimura A. ACE inhibitors and chronotherapy. Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):179-85. 

Smolensky MH, Portaluppi F.  Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am Heart J. 1999 Apr;137(4 Pt 2):S14-S24.

Lemmer B.Chronopharmacological aspects for the prevention of acute coronary syndromes. Eur Heart J. 1998 Apr;19 Suppl C:C50-8. 

Anwar YA, White WB. Chronotherapeutics for cardiovascular disease. Drugs. 1998 May;55(5):631-43.

Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996 Apr;9(4 Pt 3):11S-21S. 

Rudic RD, Fulton DJ. Pressed for time: the circadian clock and hypertension. J Appl Physiol (1985). 2009 Oct;107(4):1328-38. Epub 2009 Aug 13.Bedtime valsartan administration improved daytime to nighttime BP ratio, increasing percentage of patients with better ABPM control after treatment and decreasing urinary albumin excretion and plasma fibrinogen.

Hermida RC,Ayala DE, Calvo C. Optimal timing for antihypertensive dosing: focus on valsartan. Ther Clin Risk Manag. 2007 Mar;3(1):119-31. Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):904-22. Epub 2007 Jun 27.

Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):828-51. Epub 2007 Aug 9.

Hermida RC, Ayala DE, Calvo C. Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure.Hermida RC, Ayala DE, Calvo C. Curr Opin Nephrol Hypertens. 2005 Sep;14(5):453-9. Hermida RC, Ayala DE, Calvo C. Chronotherapy of hypertension. Curr Opin Nephrol Hypertens. 2004 Sep;13(5):501-5.

Hypertension and chronic kidney disease

Hypertension

Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Crespo JJ, Ríos MT, Moyá A, Portaluppi F. Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders. Curr Hypertens Rep. 2014 Feb;16(2):412. 

Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Vasc Health Risk Manag. 2013;9:125-33. Epub 2013 Mar 24. 

Muxfeldt ES, Salles GF. How to use ambulatory blood pressure monitoring in resistant hypertension. Hypertens Res. 2013 May;36(5):385-9. Epub 2013 Mar 21.

Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 2013 Mar;30(1-2):280-314. Epub 2012 Oct 19.

Flack JM, Nasser SA. Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag. 2011;7:777-87. Epub 2011 Dec 21.

Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens. 2011 Apr;24(4):383-91. Epub 2010 Oct 7.

Portaluppi F, Smolensky MH. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol Int. 2010 Sep;27(8):1652-67. 

Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010 Aug;15(4):173-80. 

Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure.Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):923-39. Epub 2007 Jun 28.

Hermida RC, Ayala DE, Smolensky MH, Portaluppi F. Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation. Expert Rev Cardiovasc Ther. 2007 May;5(3):463-75

Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension.Am J Hypertens. 2001 Sep;14(9 Pt 2):280S-290S.

Smolensky MH, Portaluppi F. Ambulatory blood pressure monitoring. Application to clinical medicine and antihypertension medication trials. Ann N Y Acad Sci. 1996 Aug 15;783:278-94. 

Hermida RC, Ayala DE, Smolensky MH, Mojón A, Fernández JR, Crespo JJ, Moyá A, Ríos MT, Portaluppi F. Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol. 2013 Jun;9(6):358-68. Epub 2013 Apr 23. 

Mehta R, Drawz PE. Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? Curr Hypertens Rep. 2011 Oct;13(5):378-85.